Clearance Mapping for Better Planning

Plans with lower organ-at-risk (OAR) dose, including non-coplanar VMAT plans1-21, have historically been more difficult to plan and have taken longer to deliver than simple VMAT arcs. 

MapRT helps increase the therapeutic ratio of treatment plans, making advanced and non-coplanar planning simple and safe22-24:

    • Two lateral wide-field cameras in the CT simulation room capture a full 3D surface of patients and their accessories. This includes the key collision risk areas, such as elbows and knees. 
    • This 3D surface is then used to make a “virtual treatment room”, and calculate a clearance map: which beams are safe, for every couch/gantry angle combination. 

Published evidence shows that MapRT use can improve treatment plans in around 20% of cases22. Typical increases in treatment time for clinically meaningful OAR dose reductions are 30-50 seconds per fraction22,23.

Improved assessment of deliverability

A five-center planning study24 recently showed improved assessment of deliverability using MapRT:

Modules to extend your MapRT system:

API Access in RayStation®

MapRT integrates directly with RayStation for collision checking and optimisation of non-coplanar beam angles.

API Access in Eclipse

MapRT clearance data can be accessed within Eclipse using the built-in Application Programming Interface (API).

Hear from users on their clinical experiences:


I would say 30 more seconds of treatment in exchange for 4% of lifetime coronary event risk [reduction], I will take it.”

Siqiu Wang, Medical Physics Resident, University of Texas Southwestern

“From day one, you can ensure that any plan that you have has a safe delivery, and you can reduce your need for physical collision checks.”

Adi Robinson, PhD, DABR, AdventHealth Celebration

Raystation® is a registered trademark of Raysearch Laboratories. The use of Raystation® here is for identification purposes only.
Eclipse™ is a registered trademark of Siemens Healthineers. The use of Eclipse™ here in is for identification purposes only.
Use of these marks does not indicate sponsorship, affiliation, endorsement or approval by Raysearch Laboratories or Siemens Healthineers.
MapRT uses exclusively licenced patents 62/128,906, 15/555,669, PCT/US2016/02023 4 and 16759347.4.

Frequently Asked Questions

Clinically meaningful plan improvements have been shown with only 30 seconds increase in treatment time2. Capturing the entire patient and accessory surface during simulation typically takes 1-2 minutes. Many users find MapRT helps avoid the work of physical clearance checks, and the new API enables clinics to access clearance data within their TPS.

RayStation 2025 (Photon) has a native integration with MapRT, allowing dynamic clearance checking during plan construction.

Multiple Eclipse users have scripts to view clearance maps and beam clearances inside the TPS.

The published evidence is strong that non-coplanar VMAT treatment are superior to standard VMAT. MapRT specific evidence includes a 900-patient study showing plan improvements in 18.4% of cases1, and a multicenter trial showing improved dose conformity and compactness which would not have been considered without MapRT.

1. Smyth G, et al. Recent developments in non-coplanar radiotherapy. Br J Radiol. 2019 May;92(1097):20180908.

2. Fleckenstein J, et al. Non-coplanar VMAT combined with non-uniform dose prescription markedly reduces lung dose in breath-hold lung SBRT. Strahlenther Onkol. 2018 Sep;194(9):815-823.

3. Fitzgerald R, et al. A comparison of three different VMAT techniques for the delivery of lung stereotactic ablative radiation therapy. J Med Radiat Sci. 2016 Mar;63(1):23-30.

4. Ma M, et al. Dosimetric comparison of coplanar and noncoplanar beam arrangements for radiotherapy of patients with lung cancer: A meta-analysis. J Appl Clin Med Phys. 2021 Apr;22(4):34-43.

5. Kim ST, et al. Non-coplanar VMAT plans for lung SABR to reduce dose to the heart: a planning study. Br J Radiol. 2020 Jan;93(1105):20190596.

6. Lincoln JD, et al. Static couch non-coplanar arc selection optimization for lung SBRT treatment planning. Phys Med Biol. 2023 Jul 21;68(15).

7. Chapet O, et al. Potential benefits of using non coplanar field and intensity modulated radiation therapy to preserve the heart in irradiation of lung tumors in the middle and lower lobes. Radiother Oncol. 2006 Sep;80(3):333-40.

8. Ye W, et al. Dosimetric investigation of couch rotation angles in non-coplanar VMAT plans for lung cancer SBRT. Front Oncol. 2024 Dec 24;14:1454676.

9. Frengen J, et al. Locoregional breast radiotherapy including IMN: optimizing the dose distribution using an automated non-coplanar VMAT-technique. Acta Oncol. 2023 Oct;62(10):1169-1177.

10. Xie Y, et al. Postmastectomy radiotherapy for left-sided breast cancer patients: Comparison of advanced techniques. Med Dosim. 2020 Spring;45(1):34-40.

11. Xu Y, et al. Non-coplanar volumetric modulated arc therapy for locoregional radiotherapy of left-sided breast cancer, including internal mammary nodes. Radiol Oncol. 2021 Nov 19;55(4):499-507.

12. Bharati A, et al. Dosimetric Comparison of Coplanar versus Noncoplanar Volumetric Modulated Arc Therapy for Treatment of Bilateral Breast Cancers. J Med Phys. 2023 Jul-Sep;48(3):252-258.

13. Biau J, et al. Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplanar arcs and acute toxicity outcomes from the STEREOPOSTOP GORTEC 2017-03 phase 2 trial. Clin Transl Radiat Oncol. 2022 Nov 14;38:169-174.

14. Woods KE, et al. A Prospective Phase II Study of Automated Non-Coplanar VMAT for Recurrent Head and Neck Cancer: Initial Report of Feasibility, Safety, and Patient-Reported Outcomes. Cancers (Basel). 2022 Feb 14;14(4):939.

15. Gayen S, et al. Dosimetric comparison of coplanar and non-coplanar volumetric-modulated arc therapy in head and neck cancer treated with radiotherapy. Radiat Oncol J. 2020 Jun;38(2):138-147.

16. Subramanian VS, et al. Multi-isocentric 4π volumetric-modulated arc therapy approach for head and neck cancer. J Appl Clin Med Phys. 2017 Sep;18(5):293-300.

17. Wild E, et al. Noncoplanar VMAT for nasopharyngeal tumors: Plan quality versus treatment time. Med Phys. 2015 May;42(5):2157-68.

18. Orlandi E, et al. Radiotherapy for unresectable sinonasal cancers: dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy. Radiother Oncol. 2014 Nov;113(2):260-6.

19. Nikitas J, et al. Dose-escalated stereotactic body radiotherapy re-irradiation in patients with recurrent head and neck cancer: a prospective phase 2 study using automated non-coplanar volumetric modulated arc therapy. Radiother Oncol. 2026 Jan;214:111283.

20. Rossi L, et al. On the Importance of Individualized, Non-Coplanar Beam Configurations in Mediastinal Lymphoma Radiotherapy, Optimized With Automated Planning. Front Oncol. 2021 Apr 15;11:619929.

21. Chen X, et al. Noncoplanar intensity-modulated radiation therapy for young female patients with mediastinal lymphoma. J Appl Clin Med Phys. 2012 Nov 8;13(6):3769.

22.Gonod M, et al. Benchmarking MapRT and first clinical experience: A novel solution for collision-free non-coplanar treatment planning. J Appl Clin Med Phys. 2025 Mar;26(3):e14572..

23. Siqiu Wang’s presentation at SGRT USA 2024 Meeting, “SGRT in Planning: Our Clinical Experience in Surface Guided Clearance Mapping”.

24. Sheng K, et al. Quantification of Dosimetry Improvement With or Without Patient Surface Guidance. Adv Radiat Oncol. 2024 Jul 14;9(9):101570.

Get in touch

Ready to take the next step?

Vision RT’s family of SGRT solutions guide radiation therapy for better patient care at every step: Sim, Planning, Treatment and Dose. Whether you’re looking for a quote, a product demo (virtual or in-person) or just more information, please get in touch.